Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-II patients aged between 20 and 65 year undergoing laparoscopic cholecystectomy due to gallbladder polyp or asymptomatic gallstones without cholecystitis~Exclusion Criteria:~1. Steroid therapy or immunocompromised patients~2. Diabetes mellitus~3. Allergy to lidocaine or dexamethasone~4. Severe renal dysfunction (serum creatinine more than 1.6mg/dl)~5. Severe liver disease ( liver enzymes more than two times normal values)~6. History of atrioventricular block~7. Have a difficulty in understanding QoR-40 (40-item quality-of-recovery scoring system) or Korean language~8. History of physicologic disease

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine group (Type: EXPERIMENTAL): None
- Dexamethasone group (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).